Literature DB >> 15014074

Role of the trans-activation response element in dimerization of HIV-1 RNA.

Ebbe S Andersen1, Sonia Antoranz Contera, Bjarne Knudsen, Christian K Damgaard, Flemming Besenbacher, Jørgen Kjems.   

Abstract

The HIV-1 genome consists of two identical RNA strands that are linked together through non-covalent interactions. A major determinant for efficient dimerization of the two RNA strands is the interaction between palindromic sequences in the dimerization initiation site. Here we use an interplay of bioinformatics, biochemistry, and atomic force microscopy to describe another conserved palindrome in the trans-activation response element (TAR) that functions as a strong dimerization site when transiently exposed to the viral nucleocapsid protein. In conjunction with the DIS interaction, the TAR dimerization induces the formation of a 65-nm higher-order circular structure in the dimeric HIV-1 RNA. Our results provide a molecular model for the role of TAR in packaging and reverse transcription of the viral genome. The unique structure of the TAR-TAR dimer renders it an intriguing therapeutic target for the treatment of HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15014074     DOI: 10.1074/jbc.M314326200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  A short sequence motif in the 5' leader of the HIV-1 genome modulates extended RNA dimer formation and virus replication.

Authors:  Nikki van Bel; Atze T Das; Marion Cornelissen; Truus E M Abbink; Ben Berkhout
Journal:  J Biol Chem       Date:  2014-11-03       Impact factor: 5.157

2.  Analysis of PKR activation using analytical ultracentrifugation.

Authors:  James L Cole
Journal:  Macromol Biosci       Date:  2010-07-07       Impact factor: 4.979

3.  Circularization of the HIV-1 genome facilitates strand transfer during reverse transcription.

Authors:  Nancy Beerens; Jørgen Kjems
Journal:  RNA       Date:  2010-04-29       Impact factor: 4.942

4.  Long-range RNA-RNA interactions circularize the dengue virus genome.

Authors:  Diego E Alvarez; María F Lodeiro; Silvio J Ludueña; Lía I Pietrasanta; Andrea V Gamarnik
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

5.  Single-molecule FRET studies of important intermediates in the nucleocapsid-protein-chaperoned minus-strand transfer step in HIV-1 reverse transcription.

Authors:  Hsiao-Wei Liu; Gonzalo Cosa; Christy F Landes; Yining Zeng; Brandie J Kovaleski; Daniel G Mullen; George Barany; Karin Musier-Forsyth; Paul F Barbara
Journal:  Biophys J       Date:  2005-08-12       Impact factor: 4.033

Review 6.  RNA nanotechnology: engineering, assembly and applications in detection, gene delivery and therapy.

Authors:  Peixuan Guo
Journal:  J Nanosci Nanotechnol       Date:  2005-12

7.  Characterizing complex dynamics in the transactivation response element apical loop and motional correlations with the bulge by NMR, molecular dynamics, and mutagenesis.

Authors:  Elizabeth A Dethoff; Alexandar L Hansen; Catherine Musselman; Eric D Watt; Ioan Andricioaei; Hashim M Al-Hashimi
Journal:  Biophys J       Date:  2008-07-11       Impact factor: 4.033

8.  A unique, thermostable dimer linkage structure of RD114 retroviral RNA.

Authors:  Sergei Kharytonchyk; Finn Skou Pedersen
Journal:  RNA       Date:  2010-01-14       Impact factor: 4.942

9.  HIV-1 Integrase Binds the Viral RNA Genome and Is Essential during Virion Morphogenesis.

Authors:  Jacques J Kessl; Sebla B Kutluay; Dana Townsend; Stephanie Rebensburg; Alison Slaughter; Ross C Larue; Nikoloz Shkriabai; Nordine Bakouche; James R Fuchs; Paul D Bieniasz; Mamuka Kvaratskhelia
Journal:  Cell       Date:  2016-08-25       Impact factor: 41.582

10.  RNA dimerization promotes PKR dimerization and activation.

Authors:  Laurie A Heinicke; C Jason Wong; Jeffrey Lary; Subba Rao Nallagatla; Amy Diegelman-Parente; Xiaofeng Zheng; James L Cole; Philip C Bevilacqua
Journal:  J Mol Biol       Date:  2009-05-13       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.